A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Clinical trial NCT03326193 · COMPLETED
Trial details
- NCT number
- NCT03326193
- Sponsor
- Tesaro, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2020-12-24
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.